Abstract:Although effective antiretroviral therapy (ART) suppresses HIV viral replication, prevents AIDS-related complications, and prolongs life, a proportion of patients fails to restore the patients' CD4 T cell number to the level of healthy individuals. Increased mortality and morbidity have been observed in these patients. In the current study, we have investigated the role of auto-IgGs in CD4 T cell apoptosis and recovery in a cross-sectional study. All HIV subjects were on viral-suppressive ART treatment with a … Show more
“…Several mechanisms may cause the blunted recovery of CD4 + T cells, including persistent inflammation, gut mucosal dysfunction, fibrosis of thymus, and lymphoid tissue (Hunt et al, 2003;Marchetti et al, 2008;Diaz et al, 2010;Lederman et al, 2011;Mavigner et al, 2012). In addition, increased levels of anti-CD4 IgG from non-responders induced CD4 + T cells apoptosis and play a role in poor CD4 + Tcell recovery in chronic HIV-infected individuals under ART (Luo et al, 2017a). The previous study suggests that increase of anti-CD4 IgG levels may be a novel mechanism for CD4 + T cell depletion in ART-treated chronically infected individuals.…”
Section: Discussionmentioning
confidence: 99%
“…The mechanisms of pathogenic anti-CD4 IgG production remain unknown, and persistent immune activation and inflammation after ART may contribute to the breakdown of tolerance (Xu et al, 2018). Furthermore, autoantigens from apoptotic CD4 + T cells, sCD4, or released HIV protein-bound CD4, may provide the antigen stimulation for generation of pathologic autoantibodies in post-ART HIV-infected individuals (Luo et al, 2017a). However, the exact mechanisms need further investigations.…”
Section: Discussionmentioning
confidence: 99%
“…Several mechanisms, such as persistent inflammation, fibrosis of thymus and lymphoid tissues, and gut mucosal dysfunction, are considered as factors for poor CD4 + T-cell recovery after viral-suppressive ART (Diaz et al, 2010;Kingkeow et al, 2015). Importantly, studies from others and from our team reveal that anti-CD4 autoantibodies play a role in CD4 + T cells depletion in ART-treated chronic HIV and SIV infection (Dalgleish, 1995;Kuwata et al, 2009;Luo et al, 2017a;Luo et al, 2017b). Moreover, elder age, longer duration of HIV infection and lower pre-ART CD4 + T-cell counts are associated with incomplete recovery of CD4 + T cells (Kaufmann et al, 2005;Stirrup et al, 2018).…”
Section: Introductionmentioning
confidence: 97%
“…Recently, we reported that the levels of anti-CD4 IgG are elevated in immune non-responders (aviremic, ART-treated, and CD4 + T-cell counts < 350 cells/”l) and anti-CD4 IgG purified in plasma from non-responders activates NK cells and induces CD4 + T-cell apoptosis through antibody-dependent cellular cytotoxicity (ADCC) (Lederman et al, 2011). Moreover, the percentage of surface auto-IgG on CD4 + T cells is associated with the percentage of CD4 + T-cell apoptosis and CD4 + T-cell counts under viral-suppressive ART (Luo et al, 2017a;Luo et al, 2017b). In an animal model, plasma levels of autoreactive antibodies against CD4 + T cells, but not anti-CD4 autoantibodies, was associated with progressive decline of CD4 + T cells in simian immunodeficiency virus (SIV)-infected rhesus macaques; and this association was observed in non-SIV animal models with immune activation and autoimmunity (Kuwata et al, 2009).…”
Background: Plasma levels of anti-CD4 autoantibodies are increased in chronically HIVinfected patients and inversely correlated with CD4 + T-cell recovery under viralsuppressive antiretroviral therapy (ART). However, it remains unknown the effect of early ART on plasma anti-CD4 autoantibody levels in acute HIV infection (AHI).Methods: In this cohort study, we evaluated the effect of early and delayed initiation of ART on plasma anti-CD4 autoantibody levels in AHI individuals (n = 90). Blood samples were collected from men who had sex with men (MSM) with acute infection, pre-ART, and 4, 24, 48, and 96 weeks after ART. Plasma levels of anti-CD4 immunoglobulin G (IgG) were measured by ELISA.Results: We found that plasma anti-CD4 IgG levels were significantly increased in AHI individuals compared with healthy controls (HCs) prior to ART. Notably, early ART decreased plasma anti-CD4 IgG to the levels similar to HCs starting at 24 weeks (W). However, delayed initiation of ART did not significantly reduce plasma anti-CD4 IgG levels in AHI individuals. Moreover, the peripheral CD4 + T-cell counts were inversely correlated with plasma anti-CD4 IgG levels in AHI individuals at 48 and 96 W after early ART but not after delayed ART.Conclusions: Taken together, our findings demonstrate for the first time that early ART, but not delayed initiation of ART, is effective in influencing anti-CD4 autoantibody production and recovering CD4 + T-cell counts in AHI individuals.
“…Several mechanisms may cause the blunted recovery of CD4 + T cells, including persistent inflammation, gut mucosal dysfunction, fibrosis of thymus, and lymphoid tissue (Hunt et al, 2003;Marchetti et al, 2008;Diaz et al, 2010;Lederman et al, 2011;Mavigner et al, 2012). In addition, increased levels of anti-CD4 IgG from non-responders induced CD4 + T cells apoptosis and play a role in poor CD4 + Tcell recovery in chronic HIV-infected individuals under ART (Luo et al, 2017a). The previous study suggests that increase of anti-CD4 IgG levels may be a novel mechanism for CD4 + T cell depletion in ART-treated chronically infected individuals.…”
Section: Discussionmentioning
confidence: 99%
“…The mechanisms of pathogenic anti-CD4 IgG production remain unknown, and persistent immune activation and inflammation after ART may contribute to the breakdown of tolerance (Xu et al, 2018). Furthermore, autoantigens from apoptotic CD4 + T cells, sCD4, or released HIV protein-bound CD4, may provide the antigen stimulation for generation of pathologic autoantibodies in post-ART HIV-infected individuals (Luo et al, 2017a). However, the exact mechanisms need further investigations.…”
Section: Discussionmentioning
confidence: 99%
“…Several mechanisms, such as persistent inflammation, fibrosis of thymus and lymphoid tissues, and gut mucosal dysfunction, are considered as factors for poor CD4 + T-cell recovery after viral-suppressive ART (Diaz et al, 2010;Kingkeow et al, 2015). Importantly, studies from others and from our team reveal that anti-CD4 autoantibodies play a role in CD4 + T cells depletion in ART-treated chronic HIV and SIV infection (Dalgleish, 1995;Kuwata et al, 2009;Luo et al, 2017a;Luo et al, 2017b). Moreover, elder age, longer duration of HIV infection and lower pre-ART CD4 + T-cell counts are associated with incomplete recovery of CD4 + T cells (Kaufmann et al, 2005;Stirrup et al, 2018).…”
Section: Introductionmentioning
confidence: 97%
“…Recently, we reported that the levels of anti-CD4 IgG are elevated in immune non-responders (aviremic, ART-treated, and CD4 + T-cell counts < 350 cells/”l) and anti-CD4 IgG purified in plasma from non-responders activates NK cells and induces CD4 + T-cell apoptosis through antibody-dependent cellular cytotoxicity (ADCC) (Lederman et al, 2011). Moreover, the percentage of surface auto-IgG on CD4 + T cells is associated with the percentage of CD4 + T-cell apoptosis and CD4 + T-cell counts under viral-suppressive ART (Luo et al, 2017a;Luo et al, 2017b). In an animal model, plasma levels of autoreactive antibodies against CD4 + T cells, but not anti-CD4 autoantibodies, was associated with progressive decline of CD4 + T cells in simian immunodeficiency virus (SIV)-infected rhesus macaques; and this association was observed in non-SIV animal models with immune activation and autoimmunity (Kuwata et al, 2009).…”
Background: Plasma levels of anti-CD4 autoantibodies are increased in chronically HIVinfected patients and inversely correlated with CD4 + T-cell recovery under viralsuppressive antiretroviral therapy (ART). However, it remains unknown the effect of early ART on plasma anti-CD4 autoantibody levels in acute HIV infection (AHI).Methods: In this cohort study, we evaluated the effect of early and delayed initiation of ART on plasma anti-CD4 autoantibody levels in AHI individuals (n = 90). Blood samples were collected from men who had sex with men (MSM) with acute infection, pre-ART, and 4, 24, 48, and 96 weeks after ART. Plasma levels of anti-CD4 immunoglobulin G (IgG) were measured by ELISA.Results: We found that plasma anti-CD4 IgG levels were significantly increased in AHI individuals compared with healthy controls (HCs) prior to ART. Notably, early ART decreased plasma anti-CD4 IgG to the levels similar to HCs starting at 24 weeks (W). However, delayed initiation of ART did not significantly reduce plasma anti-CD4 IgG levels in AHI individuals. Moreover, the peripheral CD4 + T-cell counts were inversely correlated with plasma anti-CD4 IgG levels in AHI individuals at 48 and 96 W after early ART but not after delayed ART.Conclusions: Taken together, our findings demonstrate for the first time that early ART, but not delayed initiation of ART, is effective in influencing anti-CD4 autoantibody production and recovering CD4 + T-cell counts in AHI individuals.
“…Potential mechanisms for poor CD4 1 T cell reconstitution are not fully understood, with possible explanations including low-nadir CD4 1 T cells, persistent immune activation, thymic insufficiency, lymphatic fibrosis, and gut mucosal dysfunction that leads to microbial translocation and inflammation (6)(7)(8)(9). Our recent study reveals that IgG anti-CD4 autoantibodies from immunologic nonresponders on virally suppressive ART (CD4 cell counts , 350 cells/ml) induced NK cell activation and antibody-dependent NK cell-mediated cytotoxicity (ADCC) against primary CD4 1 T cells (10,11).…”
Potential mechanisms of poor CD4+ T cell reconstitution after viral suppression with antiretroviral therapy (ART) in HIV disease have been extensively investigated. We recently discovered that anti-CD4 autoantibody plays a role in impaired CD4+ T cell recovery from ART in HIV-infected individuals with viral suppression, which accounts for a mechanism specific for CD4+ T cell depletion. However, the mechanism of pathologic anti-CD4 autoantibody production in treated HIV disease remains unknown. Here we report that seasonal influenza vaccination induced IgG anti-CD4 autoantibodies, predominant IgG3 subclass, in some viral-suppressed ART-treated HIV+ subjects. To explore the mechanism of anti-CD4 antibody production in this population, we performed and analyzed gene profiles in isolated B cells using a gene microarray and plasma 32 cytokines. Notably, both gene expression and multiple cytokine analyses showed pre-vaccination plasma level of IL-23 was the key cytokine linked to IgG anti-CD4 antibody production in response to immunization in vivo. Exogenous rIL-23 increased autoreactive IgG binding on CD4+ T cells from HIV+ subjects in vitro. Results from this study may reveal a role of IL-23 in anti-CD4 autoantibody production in treated HIV.
IMPORTANCE
In our published studies, we determine that pathological anti-CD4 IgGs from immunologic non-responders on virally-suppressive ART (CD4 cell counts < 350 cells/ÎŒL) mediated CD4+ T cell death via antibody-mediated cytotoxicity (ADCC), which play a role in poor CD4+ T cell recovery from ART. Up to 25% of HIV-infected individuals are non-responders and demonstrate increased morbidity and mortality. However, the mechanism of anti-CD4 autoantibody production in treated HIV remains unknown. In this study, we report that IL-23 may be the key cytokine to promote anti-CD4 autoantibody production after immunization in ART-treated HIV-infected individuals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.